TSE:IPA's free cash flow for Q4 2023 was C$-2.70M. For the 2023 fiscal year, TSE:IPA's free cash flow was decreased by C$-10.61M and operating cash flow was C$-2.23M. See a summary of the company’s cash flow.

Cash Flow	TTM	Apr 23	Apr 22	Apr 21	Apr 20	Apr 19
Operating Cash Flow	C$ -30.15M	C$ -19.83M	C$ -9.47M	C$ -600.00K	C$ -1.39M	C$ -3.21M
Investing Cash Flow	C$ -2.06M	C$ -1.97M	C$ -5.21M	C$ -2.46M	C$ -1.58M	C$ -2.20M
Financing Cash Flow	C$ -773.00K	C$ -621.00K	C$ 2.88M	C$ 43.38M	C$ 174.00K	C$ 9.35M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	C$ 39.10M	C$ 8.37M	C$ 30.05M	C$ 41.84M	C$ 2.69M	C$ 5.54M
Income Tax Paid Supplemental Data	C$ 87.00K	-	-	C$ 1.10M	C$ 238.00K	C$ 415.14K
Interest Paid Supplemental Data	C$ 263.00K	-	-	C$ 120.00K	C$ 301.00K	C$ 371.26K
Issuance Of Capital Stock	C$ 835.00K	C$ 716.00K	C$ 3.85M	C$ 44.15M	C$ 493.00K	C$ 9.84M
Issuance Of Debt	C$ -1.34M	C$ -1.34M	C$ -962.00K	C$ 2.20M	C$ 596.00K	C$ 200.00K
Repayment Of Debt	C$ -1.61M	C$ -1.34M	C$ -962.00K	C$ -2.97M	C$ -915.00K	C$ -402.69K
Free Cash Flow	C$ -31.73M	C$ -21.33M	C$ -10.72M	C$ -2.03M	C$ -1.97M	C$ -3.85M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in CAD

ImmunoPrecise Antibodies Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing